All Type of News
Drugmakers, doctors to cooperate
Cooperation between pharmaceutical firms and doctors is picking up, with efforts being made to cope with doctor’s antipathy against leading Korean drugmakers over the crackdown of doctors and pharmacists who receive w...
Drug waste to be collected by pharmaceutical firms
Korea introduced a set of measures on June 23 to contain the disposal of drug waste throughout the country.
Starting July 1 next year, pharmaceutical companies will be obliged to collect drug waste from homes and o...
Leading drugmakers joins forces with foreign R&D organizations
To seek new growth amid tight competition, more and more local drug makers are teaming up with foreign enterprises for joint tech development. For pharmaceutical companies that lack knowledge and skills, cooperating w...
Economic reform still shifts into high gear
The government reaffirmed its basic position to undertake sweeping deregulation in the broadcasting, telecom and service industries and urged corporations to increase investment and hiring.
In an open discussion o...
Drug manufacturers blamed for soaring prices
Rising OTC drug prices have triggered speculation that businesses are taking advantage of the latest inflationary pressures stemming from rising raw material costs to boost their prices.
For vitamin preparations, ...
KPMA to pick vice chairman
The Korea Pharmaceutical Manufacturers Association says it will pick its vice chairman.
Rumors have surfaced that two or three candidates are vying in the nomination.
Many say the new vice chairman should do his...
Handok, Lilly Korea to join forces in Cymbalta
Lilly Korea and Handok Pharm said on June 22 that they have agreed to join hands to market Cymbalta (duloxetine HCl) in Korea.
To this end, the two companies exchanged a letter of intent to make Cymbalta more compe...
Merck launches Collaborative Cancer Trials Network
Merck & Co said it has launched the Merck Oncology Collaborative Trials Network, a pioneering clinical trial network focusing on the development of Merck drug and vaccine candidates being investigated for the treatmen...
KFDA clarifies bioequivalence testing on transdermal drugs
The Korea Food and Drug Administration has unveiled its policy on the bioequivalence testing of oral transdermal medicines in a form of question and answer (Q/A).
The Q/A describes comparative disintegration test a...
Pharmacy schools to run 6-year programs
It is rather advisable for pharmacy colleges only to manage the 6-year pharmaceutical programs, according to a local professor.
In a recent forum, Professor Chung Kyu-hyuk of Sungkyunkwan University’s pharmacy coll...
